Skip to search.
 TSX Down 2.02% TSX Ventures Down 0.54%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
1.89 Up 0.11(6.18%) Feb 9, 4:00PM EST
Prev Close:1.78
Open:1.79
Bid:1.52 x 500
Ask:2.28 x 2300
1y Target Est:13.00
Beta:2.68404
Next Earnings Date:23-Feb-16BCRX Earnings announcement
Day's Range:1.78 - 2.09
52wk Range:1.76 - 16.83
Volume:4,916,220
Avg Vol (3m):939,100
Market Cap:138.61M
P/E (ttm):N/A
EPS (ttm):-0.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BCRXUp 6.18%138.61M
GSKDown 0.33%95.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.61
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback